These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 37398679)

  • 1. Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants?
    Carvajal Alegria G; Nicolas M; van Sleen Y
    Front Immunol; 2023; 14():1202160. PubMed ID: 37398679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
    Schmidt J; Warrington KJ
    Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
    Lally L; Spiera R
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):803-812. PubMed ID: 31427056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.
    van Sleen Y; Graver JC; Abdulahad WH; van der Geest KSM; Boots AMH; Sandovici M; Brouwer E
    Front Immunol; 2019; 10():1981. PubMed ID: 31507597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
    JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
    Emamifar A; Hess S; Gerke O; Hermann AP; Laustrup H; Hansen PS; Thye-Rønn P; Marcussen N; Svendstrup F; Gildberg-Mortensen R; Bang JC; Farahani ZA; Chrysidis S; Toftegaard P; Andreasen RA; le Greves S; Andersen HR; Olsen RN; Hansen IMJ
    Medicine (Baltimore); 2017 Jun; 96(26):e7297. PubMed ID: 28658131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polymyalgia rheumatica and Giant Cell Arteritis - Update on Diagnosis and Therapy].
    Becker M
    Praxis (Bern 1994); 2020; 109(5):347-354. PubMed ID: 32233763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant cell arteritis and polymyalgia rheumatica: an update.
    González-Gay MA; Pina T
    Curr Rheumatol Rep; 2015 Feb; 17(2):6. PubMed ID: 25618572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myalgias and Myopathies: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Mansalis K
    FP Essent; 2016 Jan; 440():16-22. PubMed ID: 26734832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
    Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Pioro MH
    Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
    Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica.
    El Chami S; Springer JM
    Rheum Dis Clin North Am; 2022 May; 48(2):493-506. PubMed ID: 35400374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
    Durkin SR; Athanasiov PA; Crompton JL
    Aust Fam Physician; 2006 Nov; 35(11):889-91. PubMed ID: 17099810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-2/-1 ratios and MMP-3 levels as an early warning sign for the presence of giant cell arteritis in patients with polymyalgia rheumatica.
    van Sleen Y; Therkildsen P; Nielsen BD; van der Geest KSM; Hansen I; Heeringa P; Posthumus MD; Sandovici M; Toonen EJM; Zijlstra J; Boots AMH; Hauge EM; Brouwer E
    Arthritis Res Ther; 2022 Mar; 24(1):65. PubMed ID: 35255968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recommendations of diagnosis and treatment of giant cell arteritis and polymyalgia rheumatic in China].
    Wang P; Feng XB; Duan XW; Liu SY; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2023 Mar; 62(3):256-266. PubMed ID: 36822851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polymyalgia rheumatica: myalgic syndrome or occult vasculitis?].
    Hellmich B; Gross WL
    Internist (Berl); 2005 Nov; 46(11):1233-43. PubMed ID: 16151786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
    Matteson EL; Buttgereit F; Dejaco C; Dasgupta B
    Rheum Dis Clin North Am; 2016 Feb; 42(1):75-90, viii. PubMed ID: 26611552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis.
    Man-Ger Sun M; Pope JE
    Best Pract Res Clin Rheumatol; 2022 Dec; 36(4):101822. PubMed ID: 36907732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?
    Salvarani C; Padoan R; Iorio L; Tomelleri A; Terrier B; Muratore F; Dasgupta B
    Autoimmun Rev; 2024 Jan; 23(1):103415. PubMed ID: 37625672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.